Aalto University spinout Canatu Oy has secured $11.3m in funding adding to a $13.5m loan provided by European Investment Bank earlier this summer.

Debiopharm has committed an eight-figure sum to recently acquired subsidiary GenePoc and has also agreed to set up a new production line.

Celgene, Novartis, GV and Taiho Ventures are among the backers that provided the funding for the Stanford-backed immuno-oncology company over two rounds.

The imaging technology spinout has attracted semiconductor manufacturer Intel as a co-lead for the round and a consortium that also included the European Investment Fund.

Tohoku University Venture Partners and others support the commercialisation of Tohoku Magnet Institute's soft magnetic alloy that could be a more efficient replacement for electromagnetic steel sheet.